Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.4
-42.02%
20%
—
88x
Every year
—
5 Years
Score4.4
Net Growth-42.02%
Net Trend20%
Net Income Consistency—
Rev Growth88x
Rev TrendEvery year
Revenue Consistency—
Axsome Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 0.00 to $ 638M and net income went from -$ 102M to -$ 183M. Revenue increased in every one of those 5 years; net income in 1.
Axsome Therapeutics Inc currently holds a 5-year HDB Score of 4.4 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-13 | $ 213.68 | — |
1 Year2025-08-13 | $ 109.39 | 95.34% |
5 Years2021-08-13 | $ 22.86 | 9x |
10 Years2016-08-12 | $ 7.44 | 28x |
All Time2015-11-19 | $ 8.74 | 24x |
| Period | Last Price2026-08-13 | 1 Year2025-08-13 | 5 Years2021-08-13 | 10 Years2016-08-12 | All Time2015-11-19 |
|---|---|---|---|---|---|
| Price | $ 213.68 | $ 109.39 | $ 22.86 | $ 7.44 | $ 8.74 |
| Return | — | 95.34% | 9x | 28x | 24x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 776M | -$ 191M | $ 319M |
| 2025 | $ 638M | -$ 183M | $ 322M |
| 2024 | $ 385M | -$ 287M | $ 315M |
| 2023 | $ 270M | -$ 239M | $ 386M |
| 2022 | $ 50M | -$ 187M | $ 200M |
| 2021 | $ 8M | -$ 134M | $ 86M |
| 2020 | $ 0.00 | -$ 102M | $ 183M |
| 2019 | $ 0.00 | -$ 68M | $ 219M |
| 2018 | $ 0.00 | -$ 30M | $ 13M |
| 2017 | $ 0.00 | -$ 28M | $ 34M |
| 2016 | $ 0.00 | -$ 27M | $ 36M |
| IPO2015 | $ 0.00 | -$ 12M | $ 48M |
Explore beyond AXSM
You're looking at Axsome Therapeutics Inc. Members apply the same fundamental framework across all 3,859 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,859 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
